Vilya
PrivateLast Round
Series A
Jun 4, 2024
Est. Valuation
$144M
Total Funding Raised
$142M
Company Overview
Vilya is a biotechnology company that develops a computational platform for creating a novel class of medicines that precisely target disease biology through the design of macrocycles.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vilya Comparables
Compare Vilya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbis Medicines | 86% | |
| Unnatural Products | 86% | |
| Curve Therapeutics | 82% | |
Vilya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2024 | ||||
| Series A | Aug 29, 2022 |
Key People
Founding team and executive leadership
Vilya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series A |
| ARCH Venture Partners | Series A |
| WRF Capital | Series A |
| Lifeforce Capital | Series A |
| ARCH Venture Partners | Series A |
| NVentures | Series A |
| Madrona Venture Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2024
$71M round led by NVentures and ARCH Venture Partners.
- Aug 29, 2022
$50M round led by ARCH Venture Partners.
Vilya Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vilya's valuation, stock price, and market status.